Workflow
Zhejiang Yangfan New Materials (300637)
icon
Search documents
扬帆新材(300637) - 2023 Q3 - 季度财报
2023-10-24 16:00
Financial Performance - The company's revenue for Q3 2023 was ¥143,770,056.41, a decrease of 21.51% compared to the same period last year[4] - The net profit attributable to shareholders for Q3 2023 was -¥3,042,724.20, representing a decline of 37.00% year-over-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥5,977,607.28, a decrease of 133.00% compared to the previous year[4] - Total operating revenue for the first three quarters was ¥526,066,171.95, a decrease of 11.3% compared to ¥593,054,621.33 in the previous year[17] - The net profit for the period was a loss of ¥6,893,803.96, compared to a profit of ¥11,137,965.35 in the same period last year[18] - The basic and diluted earnings per share were both -¥0.0294, compared to ¥0.0474 in the same period last year[18] Assets and Liabilities - The total assets as of September 30, 2023, were ¥1,373,661,389.86, down 1.13% from the end of the previous year[4] - As of September 30, 2023, total assets amounted to CNY 1,373,661,389.86, a decrease from CNY 1,389,429,540.68 at the beginning of the year, reflecting a decline of approximately 1.3%[15] - Current assets totaled CNY 399,015,269.34, down from CNY 410,695,301.12, indicating a decrease of about 2.1%[15] - Total liabilities decreased to CNY 605,672,058.24 from CNY 632,139,067.83, a reduction of about 4.2%[16] - Short-term borrowings slightly decreased to CNY 227,632,388.89 from CNY 228,155,672.48, showing a marginal decline of 0.2%[16] - The company's long-term borrowings decreased by 21.90% to ¥164,000,000.00 as of September 30, 2023[8] Cash Flow - The company's cash flow from operating activities for the first nine months of 2023 was ¥50,214,662.86, a decrease of 37.09% year-over-year[10] - The company reported a net cash inflow from operating activities of ¥50,214,662.86, down 37.0% from ¥79,825,795.82 in the previous year[19] - The company's cash flow from financing activities for the first nine months of 2023 was ¥9,761,839.45, a significant improvement compared to -¥23,872,563.63 in the same period last year[10] - Cash and cash equivalents at the end of the period were ¥76,716,035.47, an increase from ¥47,569,498.63 at the end of the previous year[20] - The company's cash and cash equivalents decreased to CNY 78,716,035.90 from CNY 96,661,841.63, a decline of approximately 18.6%[15] - The cash outflow from investing activities was ¥48,239,349.28, an improvement from a cash outflow of ¥70,401,329.50 in the previous year[20] Research and Development - The company's R&D expenses for the first nine months of 2023 were ¥29,840,717.59, down 7.92% compared to the same period last year[9] - Research and development expenses were ¥29,840,717.59, a decrease of 7.8% from ¥32,407,174.17 year-on-year[17] Other Income and Expenses - The company reported a significant increase in other income, which rose by 274.31% to ¥10,968,952.99 due to increased government subsidies[9] - The company incurred financial expenses of ¥13,034,482.46, an increase of 23.5% from ¥10,523,599.98 year-on-year[17] - Total operating costs amounted to ¥543,727,145.74, down 6.7% from ¥582,713,155.89 year-on-year[17] - The company recorded a total comprehensive income of ¥9,828,508.59, compared to ¥4,467,316.09 in the previous year[18] Equity - The company's total equity attributable to shareholders increased by 1.41% to ¥767,989,331.62 compared to the end of the previous year[4] - Total equity increased to CNY 767,989,331.62 from CNY 757,290,472.85, reflecting an increase of about 1.0%[16] - The company reported a significant reduction in accounts payable from CNY 66,746,821.07 to CNY 51,969,445.13, a decrease of approximately 22.2%[16] - The company’s long-term investments decreased from CNY 14,551,797.94 to CNY 13,377,682.27, a decline of about 8.1%[15] - The company’s other non-current financial assets increased from CNY 59,879,962.00 to CNY 79,553,270.88, representing a growth of approximately 32.9%[15]
扬帆新材:第四届监事会第九次会议决议公告
2023-10-24 08:51
证券代码:300637 证券简称:扬帆新材 公告编号:2023-038 浙江扬帆新材料股份有限公司 第四届监事会第九次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 浙江扬帆新材料股份有限公司第四届监事会第九次会议于 2023 年 10 月 23 日下午在浙江省杭州市滨江区信诚路 31 号扬帆大厦 5 楼会议室召开。公司已于 会议召开 48 小时前以通讯方式通知全体监事。会议应出席监事 3 名,实际出席 监事 3 名。会议召开符合《中华人民共和国公司法》、《公司章程》及相关法律法 规和规范性文件的规定。 本次会议由监事会主席李俊召集并主持,审议通过如下议案: 一、审议通过《关于 2023 年第三季度报告的议案》 经监事会审核公司《2023 年第三季度报告》的内容、格式、编制程序符合公 司的实际经营状况和相关法律、法规、规章制度的规定,报告真实反映了公司 2023 年第三季度的实际情况,不存在任何虚假记载、误导性陈述或者重大遗漏。 表决结果:3 票同意,0 票反对,0 票弃权;获全监事一致通过。 表决结果:3 票同意,0 票反对,0 票弃权;获全体 ...
扬帆新材:第四届董事会第十次会议决议公告
2023-10-24 08:51
证券代码:300637 证券简称:扬帆新材 公告编号:2023-037 浙江扬帆新材料股份有限公司 表决结果:7 票同意,0 票反对,0 票弃权;获全体董事一致通过。 二、审议通过了《关于修订公司独立董事工作制度的议案》 根据《公司法》、《证券法》、《上市公司独立董事管理办法》、《深圳证券交易 所创业板股票上市规则》等有关法律法规及规范性文件的最新规定,结合《公司 章程》的相关规定以及公司的实际情况,公司对《独立董事工作制度》进行了修 订。 第四届董事会第十次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 浙江扬帆新材料股份有限公司第四届董事会第十次会议于 2023 年 10 月 23 日下午在杭州市滨江区信诚路 31 号扬帆大厦五楼会议室召开。公司已于会议召 开 48 小时前以通讯方式通知全体董事。会议应出席董事 7 名,实际出席董事 7 名。会议召开符合《中华人民共和国公司法》、《公司章程》及相关法律法规和规 范性文件的规定。 本次会议由董事长召集并主持。审议通过如下议案: 一、审议通过《关于 2023 年第三季度报告的议案》 公司《2023 ...
扬帆新材:浙江扬帆新材料股份有限公司独立董事工作制度(2023年10月)
2023-10-24 08:51
第一条 为进一步完善浙江扬帆新材料股份有限公司(以下简称"公司")法人治理结构, 强化对董事会和经理层的约束和监督,提高公司决策的科学性和民主性,维护公司和全体股 东,根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共和国证券法》 (以下简称"《证券法》")等有关法律、法规以及《浙江扬帆新材料股份有限公司章程》(以 下简称"《公司章程》")的规定,遵照《深圳证券交易所创业板股票上市规则》(以下简称 "《股票上市规则》")、《上市公司独立董事管理办法》(以下简称"《管理办法》")、《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》的相关要求,结 合公司实际情况,制定本制度。 浙江扬帆新材料股份有限公司 独立董事工作制度 (2023 年 10 月) 第一章 总 则 第二条 公司独立董事是指不在公司担任除董事外的其他职务,并与公司及主要股东、 实际控制人不存在直接或者间接利害关系,或者其他可能影响其进行独立客观判断关系的董 事。 第三条 独立董事对公司及全体股东负有忠实与勤勉义务,应当按照法律、行政法规、 中国证券监督管理委员会(以下简称"中国证监会")规定、证券交易所业 ...
扬帆新材:关于调整第四届董事会审计委员会委员的公告
2023-10-24 08:51
浙江扬帆新材料股份有限公司 证券代码:300637 证券简称:扬帆新材 公告编号:2023-039 浙江扬帆新材料股份有限公司(以下简称"公司")于 2023 年 10 月 23 日 召开第四届董事会第十次会议,审议通过了《关于调整公司董事会审计委员会成 员的议案》。 根据中国证监会发布的《上市公司独立董事管理办法》中"审计委员会成 员应当为不在上市公司担任高级管理人员的董事"的规定,公司董事会同意对第 四届董事会审计委员会委员进行调整,公司董事、董事会秘书樊相东先生不再担 任审计委员会委员职务,董事会选举董事李耀土先生为审计委员会委员,与黄法 先生(召集人)、苏为科先生共同组成公司第四届董事会审计委员会,任期自本 次董事会审议通过之日起至第四届董事会届满之日止。 浙江扬帆新材料股份有限公司董事会 2023 年 10 月 25 日 关于调整公司审计委员会成员的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 ...
扬帆新材:股票交易异常波动公告
2023-09-07 12:09
证券代码:300637 证券简称:扬帆新材 公告编号:2023-034 浙江扬帆新材料股份有限公司 股票交易异常波动公告 公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 一、 股票交易异常波动的情况介绍 浙江扬帆新材料股份有限公司(证券简称:扬帆新材,证券代码:300637, 以下简称"公司"或"本公司")的股票交易价格连续 3 个交易日(2023 年 9 月 5 日、2023 年 9 月 6 日、2023 年 9 月 7 日)收盘价格涨幅偏离值累计超过 30%。 根据《深圳证券交易所交易规则》有关规定,属于股票交易异常波动的情况。 2、公司未发现近期公共传媒报道可能或已经对本公司股票交易价格产生较 大影响的未公开重大信息; 3、公司近期公司经营情况正常,内外部经营环境未发生重大变化; 4、经核查,公司控股股东和实际控制人及持股 5%以上的股东不存在关于本 公司的应披露而未披露的重大事项,也不存在处于筹划阶段的重大事项; 5、经核查,公司控股股东、实际控制人及持股 5%以上的股东在股票交易异 常波动期间不存在买卖公司股票情形; 6、与公司有关的情况不存在已发生、 ...
扬帆新材(300637) - 2023 Q2 - 季度财报
2023-08-27 16:00
Financial Performance - The company's operating revenue for the first half of 2023 was ¥382,296,115.54, a decrease of 6.73% compared to ¥409,882,118.63 in the same period last year[23]. - The net profit attributable to shareholders of the listed company was a loss of ¥3,851,079.76, representing a decline of 128.84% from a profit of ¥13,354,733.15 in the previous year[23]. - The net cash flow from operating activities decreased by 63.39%, amounting to ¥26,332,736.69 compared to ¥71,921,998.54 in the same period last year[23]. - The basic earnings per share were -¥0.02, down 133.33% from ¥0.06 in the previous year[23]. - The company reported a significant decline in net profit after deducting non-recurring gains and losses, with a loss of ¥10,123,570.95 compared to a profit of ¥13,327,383.01 in the same period last year, a decrease of 175.96%[23]. - The weighted average return on net assets was -0.51%, down from 1.73% in the previous year[23]. - The gross profit margin for the overall business was 16.29%, down 5.02% from the previous year[69]. - The revenue from photoinitiators decreased by 35.21% to CNY 80,233,635.39, with a gross margin decline of 18.72%[69]. - The revenue from thiol compounds and derivatives increased by 9.36% to CNY 297,848,255.25, with a gross margin of 22.61%[69]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,395,698,543.56, reflecting a slight increase of 0.45% from ¥1,389,429,540.68 at the end of the previous year[23]. - The net assets attributable to shareholders of the listed company increased by 0.97%, reaching ¥764,613,853.93 compared to ¥757,290,472.85 at the end of the previous year[23]. - Long-term borrowings decreased by 69.52% to CNY 64,000,000.00 from CNY 210,000,000.00, reflecting a reduction in long-term debt[72]. - Total liabilities amounted to CNY 631,084,689.63, showing a slight decrease from CNY 632,139,067.83 year-on-year[173]. - The company's cash and cash equivalents reached CNY 100,443,735.60, compared to CNY 96,661,841.63 at the start of the year, marking a growth of approximately 3.9%[168]. Market and Industry Insights - The company primarily engages in the research, production, and sales of photoinitiators and thiol compounds, establishing itself as a major supplier in the global market[30]. - The radiation curing industry has seen continuous growth since 2016, with increasing applications in semiconductor, display, and communication sectors, despite recent economic uncertainties[31]. - The global 3D printing market is projected to grow at a maximum rate of 23.7% from 2023 to 2025, with a market size expected to exceed $37 billion by 2026[38]. - The pharmaceutical market in China is expected to reach 2.3 trillion RMB by 2025, with a compound annual growth rate (CAGR) of 7.20% from 2021 to 2025[42]. - The market size of China's pharmaceutical intermediates is projected to exceed 290 billion RMB by 2026[42]. Research and Development - The company is focusing on the research and development of phosphorus-containing fine chemicals, particularly in sustainable and low-carbon manufacturing technologies[52]. - The company is committed to enhancing its R&D capabilities to maintain competitive advantages in the face of rapid technological changes[91]. - Research and development expenses decreased by 14.37% to CNY 20,110,597.39 from CNY 23,486,151.41, mainly due to reduced direct investment in R&D[68]. Environmental and Safety Compliance - The company emphasizes safety and environmental protection, adhering to relevant laws and regulations, and promoting clean production and green processes across its manufacturing bases[60][61]. - The company has established a self-monitoring plan for environmental emissions, publicly disclosing relevant pollutant discharge data in compliance with national regulations[116]. - The company reported a total wastewater discharge of 52.2 tons for COD, with a concentration of 154.60 mg/l, which is below the standard[111]. - The company has faced administrative penalties for environmental violations, including a fine of CNY 40,000 for improper storage of high-concentration organic wastewater[119]. Corporate Governance and Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares for the first half of 2023[105]. - The annual shareholders' meeting had a participation ratio of 44.72% on May 18, 2023[103]. - The company has no stock incentive plans or employee stock ownership plans in place during the reporting period[106]. - The largest shareholder, Zhejiang Yangfan Holdings, holds 22.04% of the shares, totaling 51,729,200, with a decrease of 3,877,000 shares during the reporting period[154]. Risk Management - The company faces risks from a downturn in global macroeconomic conditions, which may lead to reduced demand in downstream markets[90]. - The company has implemented measures to mitigate risks associated with rising labor costs, including improving incentive systems and enhancing automation[93]. - The company has reduced its accounts receivable compared to the previous year, but remains vigilant against potential bad debt risks due to economic slowdowns[97]. Future Outlook - The company anticipates that the radiation curing industry will continue to expand, driven by environmental regulations and technological advancements[33]. - The company is actively expanding its market presence and exploring new channels to diversify risks amid fluctuating market demands[90].
扬帆新材:董事会决议公告
2023-08-27 07:52
证券代码:300637 证券简称:扬帆新材 公告编号:2023-032 浙江扬帆新材料股份有限公司 第四届董事会第九次会议决议公告 浙江扬帆新材料股份有限公司董事会 2023 年 8 月 28 日 浙江扬帆新材料股份有限公司第四届董事会第九次会议于 2023 年 8 月 24 日 上午在杭州市滨江区信诚路 31 号扬帆大厦五楼会议室召开。公司已于会议召开 48 小时前以通讯方式通知全体董事。会议应出席董事 7 名,实际出席董事 7 名。 会议召开符合《中华人民共和国公司法》、《公司章程》及相关法律法规和规范性 文件的规定。 本次会议由董事长召集,由董事会秘书主持。审议通过如下议案: 一、审议通过《关于<2023 年半年度报告全文及其摘要>的议案》 公司《2023 年半年度报告全文及其摘要》的内容、格式、编制程序符合公 司的实际经营状况和相关法律、法规、规章制度的规定,编制期间未出现违反相 关法律、法规、规章制度和损害公司全体股东利益的情形,真实反映了公司 2023 年上半年度的实际情况。 表决结果:7 票同意,0 票反对,0 票弃权;获全体董事一致通过。 详见同日刊登在中国证监会指定创业板信息披露网站巨潮资讯 ...
扬帆新材:独立董事关于第四届董事会第九次会议相关事项发表的独立意见
2023-08-27 07:46
浙江扬帆新材料股份有限公司 浙江扬帆新材料股份有限公司独立董事 关于第四届董事会第九次会议相关事项发表的独立意见 二、关于公司对外担保情况的独立意见 经审核,截至 2023 年 6 月 30 日,公司不存在为控股股东及其他关联方、任 何非法人单位或个人提供担保的情况,也无任何除子公司外的对外担保事项,公 司当期和累计为控股股东及其关联方提供担保金额为零。 作为浙江扬帆新材料股份有限公司(以下简称"公司")的独立董事,我们参 加了公司 2023 年 8月 24 日召开的第四届董事会第九次会议,依据中国证监会《上 市公司独立董事规则》、《深圳证券交易所创业板股票上市规则》等相关法律、法 规和《公司章程》、《公司独立董事工作制度》的有关规定,我们认真履行独立董 事的工作职责,现就相关审议事项发表独立意见如下: 一、关于控股股东及其他关联方占用公司资金情况的独立意见 经审核,公司不存在控股股东及其他关联方非经营性占用公司资金的情况, 也不存在以前年度发生并累计至 2023 年 6 月 30 日的关联方违规占用资金情况。 独立董事:苏为科、张福利、黄法 2023年8月28日 ...
扬帆新材:监事会决议公告
2023-08-27 07:46
浙江扬帆新材料股份有限公司 第四届监事会第八次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 证券代码:300637 证券简称:扬帆新材 公告编号:2023-033 浙江扬帆新材料股份有限公司监事会 2023 年 8 月 28 日 经监事会审核公司《2023 年半年度报告全文及其摘要》的内容、格式、编 制程序符合公司的实际经营状况和相关法律、法规、规章制度的规定,报告真实 反映了公司 2023 年上半年度的实际情况,不存在任何虚假记载、误导性陈述或 者重大遗漏。 表决结果:3 票同意,0 票反对,0 票弃权;获全体监事一致通过。 详见同日刊登在中国证监会指定创业板信息披露网站巨潮资讯网上的相关 公告。 特此公告。 浙江扬帆新材料股份有限公司第四届监事会第八次会议于 2023 年 8 月 24 日下午在浙江省杭州市滨江区信诚路 31 号扬帆大厦 5 楼会议室召开。公司已于 会议召开 48 小时前以通讯方式通知全体监事。会议应出席监事 3 名,实际出席 监事 3 名。会议召开符合《中华人民共和国公司法》、《公司章程》及相关法律法 规和规范性文件的规定 ...